ZBHNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
ZIMMER BIOMET HOLDINGS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$94.99+0.01 (+0.01%)
Close on Oct 19, 2026
- Market cap
- $18.31B
- P/E (TTM)
- 23.1
- Dividend yield
- 1.01%
ZIMMER BIOMET HOLDINGS, INC. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Knees [Member] | $3.32B | $3.17B | $3.04B | $2.78B | $2.65B | $2.38B | $2.78B | $2.77B | $2.73B | $2.75B | 40.4% | +4.7% |
| S.E.T [Member] | $2.15B | $1.87B | $1.75B | $1.70B | $1.73B | $1.53B | $1.65B | $1.40B | $1.70B | $1.64B | 26.1% | +15.2% |
| Hips [Member] | $2.09B | $2.00B | $1.97B | $1.89B | $1.86B | $1.75B | $1.93B | $1.92B | $1.87B | $1.86B | 25.4% | +4.7% |
| Technology & Data, Bone Cement and Surgical [Member] | $665.60M | $640.30M | $636.00M | $570.00M | – | – | – | – | – | – | 8.1% | +4.0% |
| Dental [Member] | – | – | – | – | – | – | $414.00M | $411.20M | $418.60M | $427.90M | – | – |
| Other [Member] | – | – | $636.00M | $570.00M | $595.50M | $473.10M | $595.80M | $664.00M | $319.20M | $327.70M | – | – |
| Spine and CMF [Member] | – | – | – | – | – | – | $747.30M | $763.90M | $757.90M | $660.70M | – | – |
| Dental, Spine & CMFT [Member] | – | – | – | – | – | $1.04B | $1.16B | $1.18B | – | – | – | – |
| Spine & Dental [Member] | – | – | – | – | $1.01B | $897.00M | $1.02B | – | – | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas [Member] | $5.14B | $4.79B | $4.62B | $4.30B | $4.10B | $3.70B | $4.88B | $4.84B | $4.84B | $3.93B | 62.5% | +7.3% |
| United States | $4.76B | $4.44B | $4.29B | $4.01B | $3.85B | $3.51B | $4.59B | $4.56B | $4.58B | $4.53B | 57.9% | +7.3% |
| International [Member] | $3.47B | $3.24B | $3.11B | – | – | – | – | – | – | – | 42.1% | +7.0% |
| EMEA [Member] | $1.83B | $1.69B | $1.59B | $1.46B | $1.48B | $1.24B | $1.62B | $1.67B | $1.75B | $1.51B | 22.2% | +8.1% |
| Asia Pacific [Member] | $1.26B | $1.19B | $1.18B | $1.19B | $1.25B | $1.19B | $1.36B | $1.26B | $1.21B | $1.10B | 15.3% | +5.5% |
| Immaterial Product Category Operating Segments [Member] | – | – | – | – | – | – | $1.17B | $1.19B | $1.19B | $1.13B | – | – |
| Americas and Global Businesses [Member] | – | – | – | – | – | $4.48B | $5.04B | $5.00B | – | – | – | – |
| Americas Orthopedics [Member] | – | – | – | – | $4.10B | $3.70B | $4.15B | – | – | – | – | – |
| Americas Spine and Global Dental [Member] | – | – | – | – | $882.00M | $779.50M | $886.50M | – | – | – | – | – |
| International [Member] | – | $3.24B | $3.11B | $2.93B | $2.97B | $2.62B | – | – | – | – | – | – |
From the segment and revenue-disaggregation notes of Zimmer Biomet's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.